Luly Jay R.

Average Profitability
<0.0001%
Insider Buys Quantity
1
Insider Buys Sum
$256,050.00
Insider Sells Quantity
18
Insider Sells Sum
$25.96M

Insider Activity of Luly Jay R.

According to the SEC Form 4 filings, Luly Jay R., being in a position of

  1. President and CEO at Enanta Pharmaceuticals, Inc.,
    оver the last 12 months, has bought 45000 shares for $256,050, and sold 5142 shares for $41,445,
    over all time since 2014-01-02, has bought 45000 shares for $256,050, and sold 418000 shares for $25.96M.

The largest purchase of all time was on 2025-02-12 and amounted to 45000 shares of Enanta Pharmaceuticals, Inc. for $256,050.

The largest sale of all time was on 2018-07-06 and amounted to 64046 shares of Enanta Pharmaceuticals, Inc. for $8.03M.

Biography of Luly Jay R.

No biography is available at this moment.

Statistics of Insider Transactions Last Year

Amount of Insider Buys and Sells by Stocks

Buys
 $256,050150
Sells
 $41,445150

Comparison of Insiders on Amount of Buys and Sells

2025-02-12PurchaseEnanta Pharmaceuticals, Inc.
ENTA
President and CEO
45,000
0.2147%
$5.69$256,050+27.13%
2024-12-06SaleEnanta Pharmaceuticals, Inc.
ENTA
President and CEO
5,142
0.0244%
$8.06$41,445-24.63%
2023-12-05SaleEnanta Pharmaceuticals, Inc.
ENTA
President and CEO
7,230
0.0351%
$9.63$69,625+30.94%
2023-03-13SaleEnanta Pharmaceuticals, Inc.
ENTA
President and CEO
27,912
0.133%
$45.16$1.26M-67.17%
2022-12-16SaleEnanta Pharmaceuticals, Inc.
ENTA
President and CEO
30,000
0.1421%
$44.72$1.34M-48.86%
2021-09-15SaleEnanta Pharmaceuticals, Inc.
ENTA
President and CEO
4,516
0.0225%
$59.06$266,698+11.76%
2018-07-06SaleEnanta Pharmaceuticals, Inc.
ENTA
President and CEO
64,046
0.3307%
$125.38$8.03M-28.85%
2018-07-05SaleEnanta Pharmaceuticals, Inc.
ENTA
President and CEO
5,954
0.0312%
$123.81$737,136-26.82%
2018-05-17SaleEnanta Pharmaceuticals, Inc.
ENTA
President and CEO
21,936
0.1133%
$105.83$2.32M-14.8%
2018-05-16SaleEnanta Pharmaceuticals, Inc.
ENTA
President and CEO
28,064
0.146%
$105.82$2.97M-14.04%
2015-03-09SaleEnanta Pharmaceuticals, Inc.
ENTA
President and CEO
30,000
0.1585%
$33.37$1M+4.79%
2015-02-20SaleEnanta Pharmaceuticals, Inc.
ENTA
President and CEO
30,000
0.1582%
$35.35$1.06M+0.03%
2015-01-05SaleEnanta Pharmaceuticals, Inc.
ENTA
President and CEO
30,000
0.1622%
$50.43$1.51M-25.7%
2014-12-01SaleEnanta Pharmaceuticals, Inc.
ENTA
President and CEO
30,000
0.1646%
$45.39$1.36M-11.44%
2014-11-03SaleEnanta Pharmaceuticals, Inc.
ENTA
President and CEO
30,000
0.1616%
$42.52$1.28M-4.64%
2014-04-01SaleEnanta Pharmaceuticals, Inc.
ENTA
President and CEO
30,000
0.1631%
$39.17$1.18M+2.48%
2014-03-10SaleEnanta Pharmaceuticals, Inc.
ENTA
President and CEO
20,000
0.1066%
$38.49$769,734+1.6%
2014-02-14SaleEnanta Pharmaceuticals, Inc.
ENTA
President and CEO
11,600
0.0624%
$38.10$441,950+3.65%
2014-01-02SaleEnanta Pharmaceuticals, Inc.
ENTA
President and CEO
11,600
0.0627%
$28.05$325,397+39.82%
Total: 19
Company
About Prismo.proIdeasArticlesPrivacy PolicyTerms of ServiceContact Us
Screener Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksStock NewsList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.